Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents

Details

• Corporate Authors:
  Panel on Clinical Practices for the Treatment of HIV Infection (U.S.) ; Centers for Disease Control and Prevention (U.S.) ; National Institutes of Health (U.S.). Office of AIDS Research. Advisory Council.
• Description:
  Last updated July 14, 2016; last reviewed July 14, 2016).
  
  Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the advent of potent combination therapy in 1996. New drugs that offer new mechanisms of action, improvements in potency and activity even against multidrug-resistant viruses, dosing convenience, and tolerability have been approved. ART has dramatically reduced HIV-associated morbidity and mortality and has transformed HIV disease into a chronic, manageable condition. In addition, effective treatment of HIV-infected individuals with ART is highly effective at preventing transmission to sexual partners.1 However, less than one-third of HIV-infected individuals in the United States have suppressed viral loads,2 which is mostly a result of undiagnosed HIV infection and failure to link or retain diagnosed patients in care. Despite remarkable improvements in HIV treatment and prevention, economic and social barriers that result in continued morbidity, mortality, and new HIV infections persist.
  
  
• Subjects:
  Adolescent Adult Anti-HIV Agents/adverse Effects Anti-HIV Agents/therapeutic Use Antiretroviral Therapy, Highly Active/adverse Effects Antiretroviral Therapy, Highly Active/Standards Drug Resistance, Viral HIV Infections/drug Therapy HIV Infections/Immunology Pregnancy Complications, Infectious/drug Therapy Viral Load

  More +
• Document Type:
  Text
• Genre:
  Guideline
• Place as Subject:
  United States
• Collection(s):
  Guidelines and Recommendations
• Main Document Checksum:
  urn:sha-512:9e73152071115ac0860822ebc2d1f5b9a2db096fc83db6fd764ab74e86907732c0bfbd3c073b72d614531245acb2549eda41c9c3d217c5dbe217baa86400b33a
• Download URL:
  https://stacks.cdc.gov/view/cdc/7385/cdc_7385_DS1.pdf
• File Type:
  [PDF - 4.88 MB ]